This document provides information on head and neck cancer including:
1. It describes the anatomy of the head and neck region including lymph nodes and locations of salivary glands.
2. It discusses imaging techniques like CT and PET scans which are used to detect and stage head and neck cancers.
3. It outlines the AJCC TNM staging system for various head and neck cancers and describes how the cancer can spread from different primary sites.
This document provides information on head and neck cancer including:
1. It describes the anatomy of the head and neck region including lymph nodes and locations of salivary glands.
2. It discusses imaging techniques like CT and PET scans which are used to detect and stage head and neck cancers.
3. It outlines the AJCC TNM staging system for various head and neck cancers and describes how the cancer can spread from different primary sites.
Dr. KEN-LIAO LIU 劉耿僚 Pitfalls & Modifications of FDG PET-CT in Head & Neck...Ken Liao Liu
1. The document discusses common pitfalls of 18F-FDG PET/CT in head and neck oncology such as inflammation, infection, and partial volume averaging effects.
2. It provides modifications to avoid pitfalls including using a neck collar, keeping the patient quiet and warm, massaging salivary glands, and having head and neck surgeons interpret scans.
3. Proper patient preparation before PET/CT and being aware of common pitfalls are emphasized.
Dr. KEN-LIAO LIU 劉耿僚 Pitfalls & Modifications of FDG PET-CT in Head & Neck...Ken Liao Liu
1. The document discusses common pitfalls of 18F-FDG PET/CT in head and neck oncology such as inflammation, infection, and partial volume averaging effects.
2. It provides modifications to avoid pitfalls including using a neck collar, keeping the patient quiet and warm, massaging salivary glands, and having head and neck surgeons interpret scans.
3. Proper patient preparation before PET/CT and being aware of common pitfalls are emphasized.
HPV & Oral Cancer in Taiwan by Dr. Ken Liao Liu 劉耿僚Ken Liao Liu
The document discusses oral and oropharyngeal cancers in Taiwan. It finds that HPV 16 is significantly higher in cancer cases (25.4%) than controls (5.6%), especially in the oral cavity (34.2% vs 0% in controls). p53 mutation rates are higher in pharyngeal cancers than oral cavity cancers. Joint assessment of HPV and p53 status shows differences between oral cavity and pharynx cancers, with HPV playing a role in oral cavity cancers without p53 mutation.